益生菌在儿童抗生素相关性腹泻应用进展OACSTPCD
Application progress of probiotics in the antibiotic-associated diarrhea in children
抗生素相关性腹泻(AAD)是抗生素治疗后的常见并发症,其特征是肠道微生物群破坏,引起肠道短链脂肪酸(SCFA)水平降低,滞留于结肠的碳水化合物和胆汁酸增加,水和电解质吸收改变,最终导致腹泻.许多随机对照试验都显示了益生菌在预防AAD方面的益处.尽管已经报道了益生菌不良事件,但益生菌仍被广泛认为是AAD和其他胃肠道疾病安全且廉价的预防性治疗方案.文章主要就目前国内外关于益生菌干预儿童AAD作一综述,以指导益生菌合理应用.
Antibiotic-associated diarrhea(AAD)is a common complication of antibiotic treatment.It is characterized by the disruption of the gut microbiota,causing the decrease of intestinal short chain fatty acid(SCFA)concentrations,accumulation of luminal carbohydrates and colonic bile acids,changes in water and electrolyte absorption,and ultimately diarrhea.Many randomized controlled trials have shown the benefits of probiotics in preventing AAD.Although adverse events have been reported for probiotics,they still are broadly considered to be a safe and inexpensive preventative treatment option for AAD and other gastrointestinal disorders.This review summarized the effects of probiotics on children's AAD,in order to guide its rational application.
邹标;舒赛男
华中科技大学同济医学院附属同济医院儿科,湖北武汉 430030
临床医学
益生菌抗生素相关性腹泻预防治疗儿童
probioticsantibiotic-associated diarrheaprev-entiontreatmentchild
《中国实用儿科杂志》 2024 (001)
36-42 / 7
评论